Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linsitinib in Wild Type GIST
NCT01560260Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linsitinib in gastrointestinal stromal tumor (GIST), sponsored by National Cancer Institute. Started Mar 2012; status: completed.
02
Drugs
linsitinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01560260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560260.